- Credit Amounts:
- CME: 1.00
- CPE: 1.00
- KBSW: 1.00
- ADC: 1.00
- KBEP: 1.00
- Cost: Free
- Release: Nov 20, 2015
- Expires: Nov 19, 2017
- Estimated Time to Complete:
- System Requirements:
Average User Rating:
Assistant Professor of Psychiatry
Associate Program Director, Child & Adolescent Psychiatry
College of Medicine
University of Kentucky
Dr. Laurie L. Humphries Endowed Chair in Child Psychiatry
Division Director of Child and Adolescent Psychiatry
Professor of Psychiatry
Department of Psychiatry
College of Medicine
University of Kentucky
Needs StatementToday’s educational module has two components aimed to advance the learners’ knowledge in Nicotine and Cannibis use in Adolescents. Regarding the use of tobacco use in adolescents and in particular, how different tobacco products are used in this population. Of note, only a small percent of adolescent substance abuse programs provide smoking cessation treatment. There is a need to prevent the onset or intervene at an early stage of tobacco use in youth.
Cannabis use disorders and in particular, how adolescent-onset users represent a distinct clinical population. Perhaps underlying a reluctance to treat CUD remains ambivalence regarding the perceived danger of cannabis use amongst adolescents.
The expected outcome for this talk is that providers will be motivated to screen for both nicotine and cannabis use amongst their adolescent patients and be prepared to counsel them regarding the risks associated with tobacco use and early onset-cannabis use and discuss potential treatment options.
Target AudiencePhysicians, Pharmacists, Health Administrators, Nurses, Nurse Practitioners, Social Workers, Drug and Alcohol Counselors, and practitioners of addiction medicine.
ObjectivesAt the completion of this activity, the participant will be able to:
1. Review the prevalence of cannabis use in youth
2. Describe the effects of cannabis exposure in adolescents
3. Discuss the treatment of adolescent cannabis use disorder
4. Review the Prevalence of tobacco use in youth
5. Describe the effects of pre- and post-natal tobacco exposure
6. Discuss the treatment of adolescent cannabis use disorder
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Kentucky College of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.
This training has been approved by the KBML as meeting the statutory requirements of HB1.
- Patient care
- Medical knowledge
- Practice-based learning and improvement
- Interpersonal and communication skills
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This knowledge-based activity has been assigned UAN 0022-0000-15-140-H01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes completing the activity, its accompanying evaluation and/or posttest (score 70% or higher) and requesting credit online at the conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. The College complies with the Accreditation Standards for Continuing Pharmacy Education.KBSW
This activity has been approved by the Kentucky Board of Social Work for 1.00 hours. ADC
This educational activity was designated for 1.00 hour. This course is approved by the Kentucky Board of Certification of Alcohol and Drug Counselors and is co-sponsored by UKHealthCare CECentral (). KBEP
The University of Kentucky is authorized by the Kentucky Board of Examiners in Psychology to provide continuing education for psychologists.
Faculty DisclosureNo speakers, authors, or planners have any relevant financial relationships to disclose.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.